• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Press release

Toleranzia AB: BioStock: Merger strengthens Toleranzia's prospects

Toleranzia

Toleranzia and its major shareholder Flerie are proposing a merger, with Toleranzia's assets living on in an unlisted environment. The merger will improve the ability to finance the continued development of Toleranzia's drug projects while providing shareholders with a more risk-balanced exposure to Flerie's broad portfolio. BioStock contacted Charlotte Fribert, CEO of Toleranzia, and Ted Fjällman, CEO of Flerie, to learn more about the deal.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/03/merger-strengthens-toleranzias-prospects/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se